Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Payables: 2009-2024

Historic Payables for Nutex Health (NUTX) over the last 16 years, with FY2024 value amounting to $9.6 million.

  • Nutex Health's Payables rose 34060.94% to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.5 million, marking a year-over-year increase of 34060.94%. This contributed to the annual value of $9.6 million for FY2024, which is 4913.01% down from last year.
  • Per Nutex Health's latest filing, its Payables stood at $9.6 million for FY2024, which was down 4913.01% from $18.9 million recorded in FY2023.
  • In the past 5 years, Nutex Health's Payables registered a high of $23.6 million during FY2022, and its lowest value of $1.2 million during FY2020.
  • In the last 5 years, Nutex Health's Payables had a median value of $14.5 million in 2021 and averaged $13.5 million.
  • As far as peak fluctuations go, Nutex Health's Payables tumbled by 7002.85% in 2020, and later soared by 114835.2% in 2021.
  • Nutex Health's Payables (Annual) stood at $1.2 million in 2020, then skyrocketed by 1148.35% to $14.5 million in 2021, then skyrocketed by 63.31% to $23.6 million in 2022, then dropped by 19.97% to $18.9 million in 2023, then crashed by 49.13% to $9.6 million in 2024.
  • Its Payables stands at $9.6 million for FY2024, versus $18.9 million for FY2023 and $23.6 million for FY2022.